Using similar two-step mediation MR analyses, the major CHD event was also identified as the mediators of PCSK9 (5.1%) and APOC3 (26.1%) for triggering the lipid-lowering effects that extended human lifespan. The gene discussed is PCSK9; the disease is coronary artery disorder.